However, recent studies investigating the secondary EGFR T790M resistance mutation in advanced non-small cell lung cancer (NSCLC) patients showed that about 20-30% of tissue T790M mutations were not detectable in plasma-ctDNA, even with highly sensitive digital PCR technologies [7]. Here, EGFR is linked to non-small cell lung carcinoma.